ReGen Biologics, Inc.
ReGen Biologics, Inc. makes tissue implants and medical devices that are used to repair damaged or degenerating cartilage. ReGen's product line focuses on the repair and preservation of the meniscus, a piece of cartilage found in the knees. The company makes Menaflex, a collagen matrix product designed to halt deterioration, support natural regrowth of tissue, restore function, and reduce pain; the implant is approved for sale in Europe and the US (though its approval is under review in the US market). ReGen also makes the SharpShooter Tissue Repair System, a suturing device used in the Menaflex implantation procedure.
Contact Details
Executives
Chairman, President, CEO, and CFO
Gerald E. Bisbee Jr.
SVP Sales and Marketing
Jeffrey Chandler